Navigation Links
BioStorage Technologies, Inc. to Hold Global Sample Management Benchmarking Symposium in Conjunction With 2011 IIR Biorepositories Conference
Date:9/7/2011

INDIANAPOLIS, Sept. 7, 2011 /PRNewswire/ -- BioStorage Technologies, a global leader in scientific asset management, biomaterial storage and cold chain logistics, will host its third in a series of four Global Sample Management Benchmarking Symposia in conjunction with the 4th annual Biorepositories Conference on Sept. 19, 2011 in Boston. Featuring presentations from a diverse panel of multidisciplinary professionals and experts within the biobanking community, the symposium will examine strategies for outsourced and onsite management of biospecimen samples.  

"Biospecimen samples are critical scientific assets important to supporting today's research efforts, as well as validating future findings and advancing the development of novel therapies," said Gregory Swanberg, Chief Executive Officer, BioStorage Technologies. "BioStorage Technologies has been a strong supporter of the Biorepositories Conference since its inception four years ago, and holding our Global Sample Management Benchmarking in conjunction with such an impressive event was a natural fit for us."

The symposium will provide insight into trends, challenges and regulatory mandates affecting global biorepository operations, including: the emerging need for samples in specific disease areas, best practices for managing global patient consent of sample assets, onsite virtual management of sample inventories and regulatory concerns for sample management in China.

The robust speaker line up includes:

  • Dr. John Bloom, President, Bloom Consulting Services, LLC and Special Government Employee to the FDA
    "Emerging Needs in the use of Biorepositories for Drug Development: Implications for Targeted Disease Therapies and Sample Asset Management"
  • Dr. Karina Bienfait, Clinical Pharmacogenomics Operations Lead in Clinical Pharmacogenomics and Clinical Specimen Management, Merck & Company
    "Best Practices in the Management of Patient Informed Consent"
  • Steve Sweeney, Head of Clinical Technologies, Infinity Pharmaceuticals, Inc.
    "Strategies for Improving the Onsite Management of Scientific Sample Assets"
  • Suzanne M. O'Shea, Legal Counsel, Baker and Daniels LLP and former Regulatory Counsel to the U.S. Food and Drug Administration
    "Understanding How to Navigate the Regulatory Environment When Managing Samples in China"

BioStorage Technologies is also a platinum sponsor of the Biorepositories Conference, and will host several workshops at the event. Lori Ball, Chief Operating Officer, BioStorage Technologies, will co-present a workshop titled, "Manage your Biorepository to Guarantee Full Life-Cycle Specimen Quality" and Catherine Michael, Sr. Director, Comprehensive Solutions, BioStorage Technologies, will give a presentation titled, "Incorporate Quality-Control Methodologies to Identify, Control, and Eliminate Threats to Specimen Longevity and Stability."

For more information on the Global Sample Management Benchmarking Symposium, visit www.biostorage.com.

About BioStorage Technologies, Inc.:

BioStorage Technologies, Inc. is the premier, global provider of comprehensive sample management solutions for the bioscience industry. Offering onsite or outsourced management of sample assets, BioStorage Technologies manages the complete life-cycle of samples. With a team of global sample experts, state-of-the-art temperature-controlled storage facilities, and a real-time, web-based sample intelligence and tracking system, the company supports customers in maximizing opportunities, minimizing risk and reducing the cost of sample management. BioStorage Technologies, Inc. is privately held and headquartered in Indianapolis with an additional full-service site near Frankfurt, Germany. For more information, visit www.biostorage.com or call +1 (866) 697-2675 or +49-6155-898-1011.

Press Contact:
Michael Clark
Miller Brooks, Inc.
317-873-8100
michael@millerbrooks.com


'/>"/>
SOURCE BioStorage Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. BioStorage Technologies Showcases First-Ever Mobile Biorepository - Relofleet™ at Drug Information Association Annual Meeting
2. BioStorage Technologies Expands U.S. Operations with Opening of New Biorepository Facility
3. BioStorage Technologies Appoints New Director of Business Development for European Operations
4. AMDeCs Vendor Program Expands Focus with Addition of BioStorage Technologies, Offering Preferred Pricing on Tissue Storage and Cold Chain Logistics Services
5. BioStorage Technologies to Host Global Sample Management Benchmarking Symposium in Conjunction with Biorepositories Asia Conference
6. BioStorage Technologies Introduces New Version of Web-based Tracking and Sample Management System - ISISS®
7. BioStorage Technologies Appoints New Vice President of Global Sales
8. BioStorage Technologies Brings Together Industry Leaders for Global Sample Management Benchmarking Symposium
9. BioStorage Technologies, Inc., Welcomes Catherine Michael as Global Head of Sample Management Operations
10. BioStorage Technologies, Inc., Appoints Jeff Goddard to Global Head of Sales
11. BioStorage Technologies Takes Lead Sponsorship Role of 2nd Annual IIR Biorepositories Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2016)... Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global ... Directors has approved the payment of a quarterly cash dividend ... The cash dividend of $0.24 per share will be ... record as of the close of business on June 24, ... the Board of Directors and may be adjusted as business ...
(Date:5/23/2016)... ... May 23, 2016 , ... ... focused on molecular nanotechnology, announced the winners for the 2015 Foresight Institute Feynman ... Feynman, are given in two categories, one for experiment and the other for ...
(Date:5/20/2016)... ... May 20, 2016 , ... Korean researchers say Manumycin A triggers apoptosis, ... new way to treat the disease. Surviving Mesothelioma has just posted an article on ... several Korean institutions based their mesothelioma study on the fact the Manumycin A, a ...
(Date:5/19/2016)... There is no saying when ... relentless pressures in pricing and lack in consumer confidence. ... though - numerous opportunities are up for grabs but ... presents four names in this sector: Portola Pharmaceuticals Inc. ... VTAE ), Anthera Pharmaceuticals Inc. (NASDAQ: ...
Breaking Biology Technology:
(Date:3/11/2016)... March 11, 2016 --> ... research report "Image Recognition Market by Technology (Pattern Recognition), ... Advertising), by Deployment Type (On-Premises and Cloud), by Industry ... published by MarketsandMarkets, the global market is expected to ... 29.98 Billion by 2020, at a CAGR of 19.1%. ...
(Date:3/10/2016)... , March 10, 2016   Unisys Corporation (NYSE: ... Border Protection (CBP) is testing its biometric identity solution ... Diego to help identify certain non-U.S. citizens leaving ... The test, designed to help determine the efficiency and accuracy ... in February and will run until May 2016. --> ...
(Date:3/9/2016)... -- Nigeria . Recently, the ... public service employees either did not exist with their ...    --> Nigeria . Recently, ... 23,000 public service employees either did not exist with ... unlawfully.    --> DERMALOG, the biometrics innovation ...
Breaking Biology News(10 mins):